Titelia

Fund shareholders of PDS BIOTECHNOLOGY CORP

ISIN US70465T1079 · United States · LEI 5493002KU8ACFTSMC935

Fund shareholders
10
Of which ETFs
1 9 other funds
Value held
1.4M $
Share of capital
3.9 % of 56M shares on Aug 6, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 995,421602.2K $1.78 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 586,163354.6K $0.00 %1.05 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 277,144187.1K $0.00 %0.50 %as of Feb 28, 2026
iShares Micro-Cap ETF iShares Trust 118,92171.9K $0.01 %0.21 %as of Mar 31, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 67,82445.8K $0.12 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 63,76843K $0.11 %as of Feb 28, 2026
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 49,50530K $0.00 %0.09 %as of Mar 31, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 15,31210.3K $0.03 %as of Feb 28, 2026
1290 VT Micro Cap Portfolio EQ Advisors Trust 9,3045.6K $0.00 %0.02 %as of Mar 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 278270.5 $0.00 %0.00 %as of Apr 30, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.

FundWeight in fund
iShares Micro-Cap ETF iShares Trust 0.01 %as of Mar 31, 2026
1290 VT Micro Cap Portfolio EQ Advisors Trust 0.00 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 0.00 %as of Apr 30, 2026
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 0.00 %as of Mar 31, 2026

Quarter after quarter

Each SEC quarterly data set, newest first. The change is read against the quarter before it.

QuarterShareholdersChangeSharesChange
2026Q21002,183,640+2.0 %
2026Q110+12,141,824+2.7 %
2025Q49-22,084,948-13.0 %
2025Q311-22,397,249+25.1 %
2025Q213-41,915,766-2.2 %
2025Q117-51,959,283-1.1 %
2024Q422-391,981,656-36.8 %
2024Q361-253,137,148-16.3 %
2024Q286+13,748,782+3.1 %
2024Q185-13,637,699+1.5 %
2023Q4863,583,391

Institutional managers

36 managers declare this company to the SEC (Form 13F); the 25 largest follow.

ManagerSharesValue
GEODE CAPITAL MANAGEMENT, LLC660,228399.5K $as of Mar 31, 2026
BlackRock, Inc.554,048335.2K $as of Mar 31, 2026
BLAIR WILLIAM & CO/IL300,000181.5K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC220,800133.6K $as of Mar 31, 2026
INSPIRION WEALTH ADVISORS, LLC181,995110.1K $as of Mar 31, 2026
ARMISTICE CAPITAL, LLC173,605105K $as of Mar 31, 2026
STATE STREET CORP133,33380.7K $as of Mar 31, 2026
WELLS FARGO & COMPANY/MN110,50066.9K $as of Mar 31, 2026
NORTHERN TRUST CORP108,89365.9K $as of Mar 31, 2026
COMMONWEALTH EQUITY SERVICES, LLC90,79754.9K $as of Mar 31, 2026
Iron Gate Global Advisors LLC75,02245.4K $as of Mar 31, 2026
Bank of New York Mellon Corp69,31141.9K $as of Mar 31, 2026
NINE MASTS CAPITAL Ltd67,50740.8K $as of Mar 31, 2026
Tempus Wealth Planning, LLC61,80037.4K $as of Mar 31, 2026
UBS Group AG56,00433.9K $as of Mar 31, 2026
XTX Topco Ltd36,21121.9K $as of Mar 31, 2026
TWO SIGMA SECURITIES, LLC31,48119K $as of Mar 31, 2026
ACT CAPITAL MANAGEMENT, LLC30,00018.2K $as of Mar 31, 2026
Rockefeller Capital Management L.P.27,66416.7K $as of Mar 31, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP22,05213.3K $as of Mar 31, 2026
Federation des caisses Desjardins du Quebec14,8009K $as of Mar 31, 2026
Wealth Group, Ltd.13,3998 $as of Mar 31, 2026
UNITED CAPITAL FINANCIAL ADVISORS, LLC12,0007.3K $as of Mar 31, 2026
RAYMOND JAMES FINANCIAL INC10,2366.2K $as of Mar 31, 2026
GRANDFIELD & DODD, LLC10,0006.1K $as of Mar 31, 2026
Cite this page

Titelia. "Fund shareholders of PDS BIOTECHNOLOGY CORP". https://titelia.com/en/stocks/pds-biotechnology-corp-US70465T1079